Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 2
1(25.0%)
Phase 1
1(25.0%)
4Total
N/A(2)
Phase 2(1)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT01115517Phase 2Completed

Safety Study of Avastin Used as Adjunctive Therapy in Pterygium Surgery

Role: collaborator

NCT00827073Not ApplicableCompleted

Comparison of Tetracaine 0.5% and Lidocaine 2% Jelly for Topical Phacoemulsification Cataract Surgery

Role: lead

NCT00295828Phase 1Completed

A Pilot Study for the Treatment of Iris Neovascularization With Macugen

Role: lead

NCT00121147Not ApplicableCompleted

Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan

Role: lead

All 4 trials loaded